You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 83 No. 4, April 1961 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL NOTES, NEW INSTRUMENTS AND TECHNIQUES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (3)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Diphemanil Methylsulfate in Hyperhidrosis

DANIEL E. HACKBARTH, M.D.; LEONARD S. MARKSON, M.D.

Arch Dermatol. 1961;83(4):659.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Hyperhidrosis of the feet is a common problem, especially in warm climates and during summer months. It is embarrassing and uncomfortable, and can have fairly serious consequences such as maceration of the skin and exacerbation of intercurrent dermatoses. Hyperhidrosis significantly retards healing of dermatophytosis.

Formaldehyde solution, aluminum chloride, potassium permanganate, and ferric chloride are used topically with some success; however, sensitization (as with formaldehyde) or staining (as with ferric chloride and potassium permanganate) are disadvantages. Anticholinergic agents, administered orally, exert a marked anhidrotic effect through parasympathetic inhibition. Oral administration of diphemanil methylsulfate (Prantal), a quaternary ammonium compound, provides satisfactory relief of hyperhidrosis,1,2 but xerostomia and other undesired effects of parasympathetic inhibition occur in a significant number of patients. The drug is available for topical use as a 2% cream, which is effective against hyperhidrosis3 and against dermatoses in which moisture is an exacerbating factor.4,5,6 Recently, diphemanil methylsulfate . . . [Full Text PDF of this Article]


Author Affiliations

MILWAUKEE


Footnotes

Received for publication Aug. 30, 1960.

Diphemanil methylsulfate (Prantal) dusting powder (CMR-822) was provided for this clinical trial by G. Kenneth Hawkins, M.D., Department of Clinical Investigation, Medical Research Division, Schering Corporation, Bloomfield, N.J. Each gram contains 20 mg. diphemanil methylsulfate and inert powders. The powder at present is not commercially available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1961 American Medical Association. All Rights Reserved.